Table 2:

Early morbidity (1 month) in patients treated by local excision and total mesorectal excision following radiochemotherapy for rectal cancer

Morbidity	Local excision(n = 81)	TME † (n = 61)	cTME ‡ (n = 28)	P
Surgical morbidity
Rectal bleeding	8 (10)	0 (0)	0 (0)
Pelvic pain	4 (5)	1 (2)	0 (0)
Pelvic abscess	4 (5)	2 (3)	4 (14)§
Rectovaginal fistula	1 (1)	1 (2)	0 (0)
Anastomotic leakage	0 (0)	4 (7)	2 (7)
Colonic ischaemia	0 (0)	4 (7)	0 (0)
Bowel obstruction	0 (0)	5 (8)	3 (11)§
Stoma complication	0 (0)	3 (5)	0 (0)
Parietal abscess	0 (0)	3 (5)	2 (7)§
Perineal abscess	0 (0)	0 (0)	2 (7)§
Total number of complications	17 (NA)	23 (NA)	13 (NA)
Number of patients with complications	16 (20)	22 (36)	12 (43)	0.025
Medical morbidity
Urinary infection	3 (4)	2 (3)	2 (7)§
Urinary retention	1 (1)	5 (8)	4 (14)§
Prostatitis	1 (1)	0 (0)	1 (4)
Cardiac complication	1 (1)	1 (2)	0 (0)
Pneumonia	1 (1)	0 (0)	2 (7)§
Anaemia	1 (1)	0 (0)	0 (0)
Dehydration	0 (0)	4 (7)	0 (0)
Pleural effusion	0 (0)	1 (2)	0 (0)
Total number of complications	8 (NA)	13 (NA)	9 (NA)
Number of patients with complications	8 (10)	11 (18)	6 (21)	0.217
Hospital stay (days)*	3 (2–4)	10 (7–13)	16 (11–33)	<0.001

Values in parentheses are percentages unless indicated otherwise;

*values are median (i.q.r.).

^†All low anterior resection (LAR).

^‡Only morbidity of completion total mesorectal excision (cTME) itself: 23 LARs and 5 abdominoperineal resections (APRs).

^§One patient with APR. TME, total mesorectal excision.